(Q35905005)

11 August 2017

1 reference

title

MRI for assessing antivascular cancer treatments (English)

1 reference

magnetic resonance imaging

11 August 2017

main subject

0 references

author name string

Padhani AR

series ordinal

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

British Journal of Radiology

11 August 2017

published in

1 reference

11 August 2017

volume

76 Spec No 1

1 reference

11 August 2017

page(s)

S60-80

1 reference

Structural, Functional, and Molecular MR Imaging of the Microvasculature

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

In vivo monitoring of tumor angiogenesis with MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Quantification of the extraction fraction for gadopentetate across breast cancer capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Methodology of brain perfusion imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Contrast agents in functional MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Comparison of gradient- and spin-echo imaging: CBF, CBV, and MTT measurements by bolus tracking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

NMR imaging of changes in vascular morphology due to tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Contrast agents and cerebral hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

A reinvestigation of maximal signal drop in dynamic susceptibility contrast magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Comparison of Gd- and Dy-chelates for T2* Contrast-Enhanced Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Contrast-to-noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

MRI in acute cerebral ischaemia: perfusion imaging with superparamagnetic iron oxide in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Cerebral perfusion imaging using contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Comparison of cerebral blood volume measurements using the T1 and T2* methods in normal human brains and brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Gliomas: correlation of magnetic susceptibility artifact with histologic grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Breast disease: dynamic spiral MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Key factors in the acquisition of contrast kinetic data for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Modeling tracer kinetics in dynamic Gd-DTPA MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Quantification of blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Transcytolemmal water exchange and its affect on the determination of contrast agent concentration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Determining and optimizing the precision of quantitative measurements of perfusion from dynamic contrast enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhancedT1-weighted MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Microvessel density in invasive breast cancer assessed by dynamic gd-dtpa enhanced MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Breast Combined with Pharmacokinetic Analysis of Gadolinium-DTPA Uptake in the Diagnosis of Local Recurrence of Early Stage Breast Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Dynamic contrast-enhanced magnetic resonance imaging at 1.5 Tesla with gadopentetate dimeglumine to assess the angiostatic effects of anginex in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Transport of molecules across tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Microvascular permeability of normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Optimizing imaging techniques to reduce errors in microvascular quantitation with macromolecular MR contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

The role of angiogenesis, vascular maturation, regression and stroma infiltration in dormancy and growth of implanted MLS ovarian carcinoma spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Differentiating Benign and Malignant Breast Lesions with T2*-Weighted First Pass Perfusion Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15334380

21 January 2018

Identifiers

DOI

10.1259/BJR/15334380

1 reference

11 August 2017

1 reference